ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 706,89
0,00%
Dow Jones
39 411,21
0,67%
DAX
18 325,58
0,77%
Brent Oil
85,245
-0,03%
Bitcoin
60 983,03
1,20%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Apogee Therapeutics Inc (APGE)

  7. Apogee Therapeutics Inc (APGE) Actualités

APGE Apogee Therapeutics Inc

39,00
1,00 (2,63%)
25 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Apogee Therapeutics Inc APGE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,00 2,63% 39,00 01:46:53
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
38,03 37,61 41,0584 39,00 38,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/6/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:02EDGAR2Form 8-K - Current report
31/5/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202402:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/5/202413:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/5/202413:35EDGAR2Form 8-K - Current report
28/5/202413:30GLOBEApogee Therapeutics Expands Board of Directors with the..
23/5/202413:30GLOBEApogee Therapeutics to Participate in Upcoming June Investor..
15/5/202422:01GLOBEApogee Announces Dosing of First Patient in Phase 2 Atopic..
13/5/202413:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/5/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:05EDGAR2Form 8-K - Current report
13/5/202413:00GLOBEApogee Therapeutics Highlights Pipeline Progress and Reports..
06/5/202414:00GLOBEApogee Therapeutics to Participate at the 2024 Bank of..
25/3/202412:00GLOBEApogee Therapeutics Announces First Participants Dosed in..
12/3/202421:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..
11/3/202411:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
08/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/3/202400:49GLOBEApogee Therapeutics, Inc. Announces Pricing of Upsized $420..
08/3/202400:27EDGAR2Form S-1MEF - Registration adding securities to prior Form..
05/3/202422:23GLOBEApogee Therapeutics, Inc. Announces Proposed..
05/3/202422:05EDGAR2Form S-1 - General form for registration of securities under..
05/3/202414:15EDGAR2Form 8-K - Current report
05/3/202412:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202412:11EDGAR2Form 8-K - Current report
05/3/202412:10GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
05/3/202412:00GLOBEApogee Announces Positive Interim Results from Phase 1..
04/3/202422:01GLOBEApogee to Host Conference Call and Webcast to Report Interim..
02/1/202413:30GLOBEApogee Therapeutics to Present at the 42nd Annual J.P...
21/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:41EDGAR2Form 8-K - Current report
13/11/202313:30GLOBEApogee Highlights Corporate Progress and Reports Third..
30/10/202313:00GLOBEApogee Therapeutics to Participate in Upcoming November..
27/9/202314:42GLOBEApogee Announces Two Abstracts Accepted for Presentation at..
14/9/202313:30GLOBEApogee Therapeutics to Participate at the 2023 Stifel..
29/8/202314:00PRNUSParagon Therapeutics Recognizes Key Milestones and..
28/8/202313:30GLOBEApogee Highlights Corporate Progress and Reports Second..
21/8/202313:30GLOBEApogee Therapeutics Appoints Mark C. McKenna, Healthcare..
07/8/202313:30GLOBEApogee Announces First Participants Dosed Ahead of Schedule..
02/8/202313:30GLOBEApogee Therapeutics to Participate in Upcoming August..
18/7/202322:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..

Dernières Valeurs Consultées

NASDAQ
APGE
Apogee Therapeutics
EU
BEB157590931
Belfius 2.4% until 16mar24
BOV
SNSY5M
SANSUY PNA
LSE
ROC
Rockpool Acquisitions
FX
LBPUSD
LBP vs US Dollar
TG
K6S
Mira Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés